Recombinant angiotensin II therapy in a child with cardiac dysfunction and Pandoraea and Candida sepsis
Cardiology in the young(2023)
Abstract
Recombinant angiotensin II is an emerging drug therapy for refractory hypotension. Its use is relevant to patients with disruption of the renin-angiotensin-aldosterone system denoted by elevated direct renin levels. We present a child that responded to recombinant angiotensin II in the setting of right ventricular hypertension and multi-organism septic shock.
MoreTranslated text
Key words
Hemodynamics,perfusion,pulmonary hypertension,acute heart failure,inotropes
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined